Role of IFNe in immune modulation and HIV infection
IFNe在免疫调节和HIV感染中的作用
基本信息
- 批准号:10356898
- 负责人:
- 金额:$ 60.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAcuteBiological Response ModifiersBiopsyBloodCellsCervicalChronicClinicalDataDiseaseE proteinEffector CellElementsEstrogen TherapyEstrogensExhibitsExposure toFemaleGene ExpressionGene Expression RegulationGenesGoalsHIVHIV InfectionsHIV SeronegativityHIV resistanceHumanIFNAR1 geneImmuneImmune responseImmunityIn VitroInfectionInterferon-alphaInterferonsKnowledgeMediatingMenstrual cycleModelingMolecularMolecular CloningMucosal ImmunityMucous MembranePeripheralPeripheral Blood Mononuclear CellPhagocytosisPlasmaPlayPostmenopausePredispositionProcessProductionPropertyPublishingReactive Oxygen SpeciesRegulationResearchResistanceRoleSamplingSeminal PlasmaSeminal fluidSexually Transmitted DiseasesSignal TransductionTestingTissuesToll-Like Receptor PathwayVaginaVariantViralViral Load resultViral PhysiologyViral reservoirVirusWomancervical biopsycervicovaginalchronic infectionclinically relevantcohortcytokinedifferential expressionhumanized mouseimmune activationimmune functionimmunoregulationin vivolongitudinal analysismacrophagemouse modelpreventreceptorrecruitreproductive tractresistant strainsextranscriptometransmission processvirus host interaction
项目摘要
Project Summary
Interferon e (IFNe) is a critical innate immune mediator that protects the host against sexually transmitted
infections. Although the current paradigm is that IFNε is a type I IFN and signals through IFNa receptors, our
and other published results show that IFNε has unique immune functions that are distinct from IFNa/b. IFNε is
highly abundant in the mucosa of the female reproductive tract, and has superior mucosal immune activity
compared to IFNa/b. IFNe gene expression is regulated by estrogen, cytokines, and seminal plasma, but is not
induced by Toll-like receptor pathways, which induce IFNa/b. Clinical evidence indicates a protective role of
IFNe against HIV. IFNe expression is positively associated with estrogen levels during the menstrual cycle, and
inversely correlates with HIV susceptibility. Importantly, HIV-negative sex workers with frequent exposure to
semen have an increased level of IFNe gene expression, and have increased numbers of immune effector
cells in cervical tissues. We recently demonstrate that IFNe induces an anti-HIV state through a mechanism
independent of known type I IFN-induced HIV host restriction factors in primary macrophages. Additionally,
IFNε elicits a more robust immune response than IFNa2. We hypothesize is that IFNe displays a dual role in
HIV inhibition by protecting HIV target cells and by modulating immune functions, and will test our hypothesis
by determining the immune mechanism of IFNe and its impact on HIV infection in vitro, cervical explants and in
humanized mouse model. To gain a better understanding of the molecular mechanism of IFNe-mediated HIV
inhibition, we determine viral determinants important for IFNe sensitivity. Because estrogen is known to
modulate IFNe expression and mucosal immunity, we will assess the impact of estrogen on IFNε-mediated
processes in HIV infection in postmenopausal women before and after estrogen treatment. Elucidating the
properties and functions of IFNe promises to expand our knowledge of virus-host interactions crucial for HIV
prevention and control of viral reservoirs and immunopathogenesis.
项目摘要
干扰素e(IFNe)是一种重要的先天免疫介质,可保护宿主免受性传播疾病的侵害。
感染.尽管目前的范例是IFNε是I型IFN并且通过IFN α受体发出信号,但我们的研究发现,
和其他已发表的结果表明,IFNε具有不同于IFN α/B的独特免疫功能。IFNε是
在雌性生殖道粘膜中高度丰富,并具有上级粘膜免疫活性
与IFNa/B相比。IFNe基因表达受雌激素、细胞因子和精浆的调节,但不受雌激素、细胞因子和精浆的调节。
由Toll样受体途径诱导,其诱导IFN α/B。临床证据表明,
IFNe抗艾滋病毒。IFNe表达与月经周期中的雌激素水平呈正相关,
与HIV易感性呈负相关。重要的是,艾滋病毒阴性的性工作者经常接触
精液中IFNe基因表达水平增加,免疫效应子数量增加
宫颈组织中的细胞。我们最近证明,IFNe通过一种机制诱导抗HIV状态,
独立于原代巨噬细胞中已知的I型IFN诱导的HIV宿主限制因子。此外,本发明的目的是,
IFNε比IFN α 2产生更强的免疫应答。我们假设IFNe在以下方面显示出双重作用:
通过保护HIV靶细胞和调节免疫功能来抑制HIV,并将验证我们的假设
通过确定IFNe的免疫机制及其对体外HIV感染的影响,
人源化小鼠模型。为了更好地了解IFN介导的HIV的分子机制,
抑制,我们确定了IFNe敏感性重要的病毒决定因素。因为众所周知雌激素
调节IFNe表达和粘膜免疫,我们将评估雌激素对IFNε介导的影响
绝经后妇女雌激素治疗前后的HIV感染过程。阐明
IFNe的性质和功能有望扩大我们对HIV病毒-宿主相互作用的认识
预防和控制病毒储库和免疫发病机制。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro.
- DOI:10.3390/pathogens10030272
- 发表时间:2021-03-01
- 期刊:
- 影响因子:0
- 作者:Xu C;Wang A;Hoskin ER;Cugini C;Markowitz K;Chang TL;Fine DH
- 通讯作者:Fine DH
Brilacidin, a Non-Peptide Defensin-Mimetic Molecule, Inhibits SARS-CoV-2 Infection by Blocking Viral Entry.
Brilacidin 是一种非肽防御素模拟分子,通过阻止病毒进入来抑制 SARS-CoV-2 感染。
- DOI:
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Xu,Chuan;Wang,Annie;Honnen,William;Pinter,Abraham;Weston,WarrenK;Harness,JaneA;Narayanan,Aarthi;Chang,TheresaL
- 通讯作者:Chang,TheresaL
Multifaceted immune functions of human defensins and underlying mechanisms.
人防御素和潜在机制的多方面免疫功能。
- DOI:10.1016/j.semcdb.2018.02.023
- 发表时间:2019-04
- 期刊:
- 影响因子:7.3
- 作者:Fruitwala S;El-Naccache DW;Chang TL
- 通讯作者:Chang TL
Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.
- DOI:10.3390/v13060953
- 发表时间:2021-05-21
- 期刊:
- 影响因子:0
- 作者:Xu C;Wang A;Geng K;Honnen W;Wang X;Bruiners N;Singh S;Ferrara F;D'Angelo S;Bradbury ARM;Gennaro ML;Liu D;Pinter A;Chang TL
- 通讯作者:Chang TL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Theresa L Chang其他文献
Theresa L Chang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Theresa L Chang', 18)}}的其他基金
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
- 批准号:
10654740 - 财政年份:2021
- 资助金额:
$ 60.28万 - 项目类别:
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
- 批准号:
10462764 - 财政年份:2021
- 资助金额:
$ 60.28万 - 项目类别:
Impact of gender affirming hormone therapy on immune modulation and HIV infection in transgender young adults
性别肯定激素治疗对跨性别年轻人免疫调节和艾滋病毒感染的影响
- 批准号:
10364706 - 财政年份:2021
- 资助金额:
$ 60.28万 - 项目类别:
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
- 批准号:
10327456 - 财政年份:2021
- 资助金额:
$ 60.28万 - 项目类别:
Impact of gender affirming hormone therapy on immune modulation and HIV infection in transgender young adults
性别肯定激素治疗对跨性别年轻人免疫调节和艾滋病毒感染的影响
- 批准号:
10257722 - 财政年份:2021
- 资助金额:
$ 60.28万 - 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
- 批准号:
9045100 - 财政年份:2013
- 资助金额:
$ 60.28万 - 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
- 批准号:
8716673 - 财政年份:2013
- 资助金额:
$ 60.28万 - 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
- 批准号:
8885647 - 财政年份:2013
- 资助金额:
$ 60.28万 - 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
- 批准号:
8593906 - 财政年份:2013
- 资助金额:
$ 60.28万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 60.28万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 60.28万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 60.28万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 60.28万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 60.28万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 60.28万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 60.28万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 60.28万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 60.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 60.28万 - 项目类别:
Standard Grant














{{item.name}}会员




